| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2002PNAS...9910718K |
| P356 | DOI | 10.1073/PNAS.152597199 |
| P932 | PMC publication ID | 125023 |
| P698 | PubMed publication ID | 12149448 |
| P5875 | ResearchGate publication ID | 11234188 |
| P2093 | author name string | Tadashi Wada | |
| Taeko Miyagi | |||
| Ikuro Sato | |||
| Kazunori Yamaguchi | |||
| Yoichiro Kakugawa | |||
| Kiyoaki Ouchi | |||
| Hideaki Yamanami | |||
| P2860 | cites work | Cloning, expression, and chromosomal mapping of a human ganglioside sialidase | Q22010257 |
| Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis | Q24310793 | ||
| Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase | Q24321859 | ||
| c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression | Q28289341 | ||
| Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides | Q31905229 | ||
| Identification of a sialidase encoded in the human major histocompatibility complex | Q34415395 | ||
| Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis | Q34418454 | ||
| Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. | Q34438239 | ||
| Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. | Q35264401 | ||
| Ecdysone-inducible gene expression in mammalian cells and transgenic mice. | Q37651825 | ||
| Glycopeptide changes and malignant transformation a possible role for cabohydrate in malignant behavior | Q39776332 | ||
| The plasma membrane ganglioside sialidase cofractionates with markers of lipid rafts | Q40806667 | ||
| p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells | Q40810981 | ||
| Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells | Q41113010 | ||
| Elevation of an alpha(1,3)fucosyltransferase activity correlated with apoptosis in the human colon adenocarcinoma cell line, HT-29. | Q41147606 | ||
| Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism | Q41270282 | ||
| Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate | Q41419600 | ||
| Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures | Q41437200 | ||
| Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity | Q41450272 | ||
| Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation | Q41479510 | ||
| Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer | Q41526050 | ||
| Perspectives on the significance of altered glycosylation of glycoproteins in cancer | Q41594921 | ||
| Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29 | Q41603400 | ||
| Tumor-promoting phorbol ester induces alterations of sialidase and sialyltransferase activities of JB6 cells | Q41712959 | ||
| Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation | Q41936747 | ||
| Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells | Q43606516 | ||
| Metastatic Potential Is Positively Correlated with Cell Surface Sialylation of Cultured Murine Tumor Cell Lines | Q44789681 | ||
| Sialidase activity in transformed cells | Q44790959 | ||
| Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate | Q46242843 | ||
| Signal transduction through glyco(sphingo)lipids. Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains. | Q47826013 | ||
| Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation | Q47878199 | ||
| Purification and characterization of a membrane-associated ganglioside sialidase from bovine brain | Q48447652 | ||
| Partial characterization and enrichment of a membrane-bound sialidase specific for gangliosides from human brain tissue | Q48606477 | ||
| Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain | Q48974288 | ||
| Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. | Q53529803 | ||
| GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion | Q57082830 | ||
| Glycosphingolipids in human colonic adenocarcinoma | Q67294711 | ||
| Glycolipids of metastatic tissue in liver from colon cancer: appearance of sialylated Le(x) and Le(x) lipids | Q67931259 | ||
| Cell surface sialic acid and the invasive and metastatic potential of T-cell hybridomas | Q68798292 | ||
| Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) | Q70590724 | ||
| Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells | Q71140148 | ||
| Human colon sialidase: characterization and activity levels in normal mucosa and colonic adenocarcinoma | Q71501198 | ||
| A monoclonal antibody directed to N-acetylneuraminosyl-alpha 2 leads to 6-galactosyl residue in gangliosides and glycoproteins | Q72712325 | ||
| Induction of terminal differentiation and apoptosis in human colonic carcinoma cells by brefeldin A, a drug affecting ganglioside biosynthesis | Q77993715 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| colon cancer | Q18555025 | ||
| P304 | page(s) | 10718-10723 | |
| P577 | publication date | 2002-07-29 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression | |
| P478 | volume | 99 |
| Q40164019 | A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells |
| Q30479559 | A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. |
| Q48592013 | A light-up imaging protocol for neutral pH-enhanced fluorescence detection of lysosomal neuraminidase activity in living cells |
| Q37347015 | Aberrant expression of sialidase and cancer progression |
| Q48532597 | Activity of lysosomal exoglycosidases in human gliomas |
| Q50540781 | Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma. |
| Q40565674 | Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP. |
| Q90741842 | Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-/-) mice |
| Q37686168 | Carbohydrate-containing molecules as potential biomarkers in colon cancer |
| Q34034577 | Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages |
| Q91693306 | Colon Cancer and Perturbations of the Sphingolipid Metabolism |
| Q35837213 | Colon cancer: genomics and apoptotic events |
| Q48698146 | Conditional LoxP-flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis |
| Q47672234 | Contribution of neuraminidase 3 to the differentiation of induced regulatory T cells |
| Q46158192 | Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4. |
| Q40479078 | Cytochemical study of role of alpha-d-mannose- and beta-d-galactose-containing glycoproteins in apoptosis. |
| Q47247441 | Deregulation of sialidases in human normal and tumor tissues. |
| Q33649446 | Differential Plasma Glycoproteome of p19 Skin Cancer Mouse Model Using the Corra Label-Free LC-MS Proteomics Platform |
| Q39561058 | Differential carbohydrate binding and cell surface glycosylation of human cancer cell lines. |
| Q96304772 | Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules |
| Q61799319 | Establishing an osteoimmunomodulatory coating loaded with aspirin on the surface of titanium primed with phase-transited lysozyme |
| Q36332756 | Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting |
| Q38240473 | Exploring the link between ceramide and ionizing radiation |
| Q37632845 | Fine tuning of cell functions through remodeling of glycosphingolipids by plasma membrane-associated glycohydrolases |
| Q36414548 | Fluorogenic sialic acid glycosides for quantification of sialidase activity upon unnatural substrates. |
| Q46623333 | Ganglioside Intake Increases Plasma Ganglioside Content in Human Participants |
| Q39949212 | Ganglioside composition of differentiated Caco-2 cells resembles human colostrum and neonatal rat intestine |
| Q35824021 | Ganglioside/glycosphingolipid turnover: new concepts |
| Q37671122 | Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression |
| Q39298073 | Glycoengineering of CHO Cells to Improve Product Quality |
| Q24649767 | Glycolipid transfer protein mediated transfer of glycosphingolipids between membranes: a model for action based on kinetic and thermodynamic analyses |
| Q26750872 | Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer |
| Q35671116 | Glycosphingolipids and cell death |
| Q34074081 | Glycosylation defining cancer malignancy: new wine in an old bottle |
| Q38569702 | Glycosylation in cancer: mechanisms and clinical implications |
| Q33267875 | High-throughput substrate specificity studies of sialidases by using chemoenzymatically synthesized sialoside libraries |
| Q38335675 | Human lysosomal α-D-mannosidase regulation in promyelocytic leukaemia cells. |
| Q42757281 | Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies. |
| Q35538440 | Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum |
| Q38169157 | Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer |
| Q38571156 | Interleukin-6 as an emerging regulator of renal cell cancer |
| Q39347185 | Ionizing radiations increase the activity of the cell surface glycohydrolases and the plasma membrane ceramide content. |
| Q34378741 | LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity |
| Q40280751 | Lactosylceramide is required in apoptosis induced by N-Smase |
| Q33264136 | Mechanism-based inhibitors to probe transitional states of glycoside hydrolases |
| Q39479013 | Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides |
| Q39253858 | Methylation status of TUSC3 is a prognostic factor in ovarian cancer |
| Q46757649 | Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage |
| Q57357376 | Modification of sialidase levels and sialoglycoconjugate pattern during erythroid and erytroleukemic cell differentiation |
| Q36994568 | Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane. |
| Q41826097 | Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio). |
| Q24307924 | Molecular cloning and characterization of NEU4, the fourth member of the human sialidase gene family |
| Q35217621 | Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles. |
| Q41510497 | NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes |
| Q53189212 | NEU4L sialidase overexpression promotes β-catenin signaling in neuroblastoma cells, enhancing stem-like malignant cell growth. |
| Q24297476 | Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells |
| Q24647879 | Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2 |
| Q47146342 | Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3. |
| Q24301037 | Overexpression of Plasma Membrane-associated Sialidase Attenuates Insulin Signaling in Transgenic Mice |
| Q39391765 | Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers. |
| Q35657424 | Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling |
| Q38269449 | Plasma membrane-associated sialidase confers cancer initiation, promotion and progression |
| Q24541434 | Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling |
| Q50921969 | Possible association of Neu2 with plasma membrane fraction from mouse thymus exhibited sialidase activity with fetuin at pH 7.0 but not at pH 4.5. |
| Q35585497 | Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation |
| Q33649823 | Re-configuration of sphingolipid metabolism by oncogenic transformation |
| Q48362826 | Recurrent infection progressively disables host protection against intestinal inflammation. |
| Q28729113 | Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase |
| Q37474841 | Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis |
| Q33675552 | Regulation of intracellular signaling by extracellular glycan remodeling. |
| Q39552528 | Regulation of sialyl Lewis antigen expression in colon cancer cells by sialidase NEU4. |
| Q37823410 | Remodeling of sphingolipids by plasma membrane associated enzymes. |
| Q40181904 | Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites |
| Q35138120 | Role of tumor-associated gangliosides in cancer progression |
| Q55410162 | Serum sialylation changes in cancer. |
| Q38620799 | Sialic acids in cancer biology and immunity. |
| Q90274752 | Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway |
| Q42187978 | Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures |
| Q30351350 | Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication. |
| Q35748328 | Sialidase and malignancy: a minireview |
| Q38014310 | Sialidase significance for cancer progression |
| Q35678457 | Sialidases as regulators of bioengineered cellular surfaces. |
| Q37788386 | Sialidases in vertebrates: a family of enzymes tailored for several cell functions |
| Q34590044 | Sialoside-based pattern recognitions discriminating infections from tissue injuries |
| Q93382557 | Sialylation is involved in cell fate decision during development, reprogramming and cancer progression |
| Q38750232 | Silencing of ST6Gal I enhances colorectal cancer metastasis by down-regulating KAI1 via exosome-mediated exportation and thereby rescues integrin signaling |
| Q46344190 | Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. |
| Q34213758 | Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis |
| Q38195691 | Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance |
| Q33509329 | Structural analysis of glycosphingolipid analogues obtained by the saccharide primer method using CE-ESI-MS. |
| Q26750877 | The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression |
| Q33609838 | The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells |
| Q38166684 | The glycosphingolipid hydrolases in the central nervous system |
| Q36467422 | Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis |
| Q38022218 | Using lectins to harvest the plasma/serum glycoproteome. |
| Q39034253 | Visualization of sialidase activity in Mammalian tissues and cancer detection with a novel fluorescent sialidase substrate |
| Q40419399 | Zanamivir: an influenza virus neuraminidase inhibitor |
Search more.